Oxypertine and Medazepam in Patients Suffering from Anxiety Neurosis. Report of a Double Blind Study
In two centres a total of 50 patients with anxiety neurosis was studied in a randomised, between patient, double blind comparison of the therapeutic efficacies of two new anxiolytic agents, oxypertine ( Integrin) and medazepam ( Nobrium). Treatment was continued for four weeks. Assessments were made using the Middlesex Hospital Questionnaire ( MHQ), the Hamilton Anxiety Scale and the Graphic Scale. On all three ratings both agents produced a significant improvement in the patients' condition. Significant differences between the two agents were recorded by the MHQ sub tests and total score. Phobic anxiety responded significantly better to medazepam ( p < 0·03). Depression responded significantly better to oxypertine ( p < 0·02) which was also associated with a greater improvement in three of the remaining four sub tests and a significantly greater reduction in score for overall neuroticism ( p < 0·05).